BSEInsider Trading / SAST2h ago · 25 Sept 2026, 04:20 pm
Closure of Trading Window
Akums Drugs and Pharmaceuticals Ltd · 544222
✦ AI SummaryRegulatory
Akums Drugs and Pharmaceuticals Ltd has announced the closure of its trading window for all designated persons, including their immediate relatives, from October 1, 2026, until 48 hours after the declaration of unaudited financial results for the quarter ending September 30, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst3/10
Governance Concern2/10
Regulatory Risk8/10
Balance Sheet Risk4/10
Liquidity Impact6/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Akums Drugs and Pharmaceuticals Ltd - 544222 - Closure of Trading Window
Attachments (1)
📄pdf
Download →
85b56aad-5061-4881-a24e-e36ff947321f.pdf
View document text
Ref: Akums/Exchange/2026-27/51 September 25, 2026
To, To,
The Listing Department The Listing Department
National Stock Exchange of India Ltd BSE Limited
Exchange Plaza, C-1, Block G, 25th Floor, New Trading Ring,
Bandra Kurla Complex, Rotunda Building, Phiroze Jeejeebhoy
Bandra (E), Mumbai – 400 051 Towers, Dalal Street, Mumbai – 400 001
Scrip Code: 544222
Symbol: AKUMS
Sub: Closure of Trading Window
Respected Sir/Ma’am,
This is to inform you that in compliance with the SEBI (Prohibition of Insider Trading)
Regulations, 2015 and the ''Code of Conduct to Regulate, Monitor and Report Trading by
designated persons in securities of the Company'', the trading window for dealing in
securities of the Company will be closed for all the designated persons (including their
immediate relatives) from 1st October, 2026 and shall remain closed till 48 hrs. after the
declaration of un-audited (Standalone & Consolidated) Financial Results of the Company for
the quarter ending 30th September, 2026.
Further, the date of meeting of the Board of Directors of the Company to consider and
approve the un-audited (Standalone & Consolidated) Financial Results of the Company for
the aforesaid periods shall be intimated in due course.
This is for your information and records.
Thanking You
For Akums Drugs and Pharmaceuticals Limited
Dharamvir Malik
Company Secretary & Compliance Officer